Fiche du titre · trimestre archivé

LLY

Eli Lilly and Company · Healthcare · Drug Manufacturers - General

1,233.5 -1.1% cap. boursière $1.16T cours différé (FMP) · au Aug 25 22:08 UTC — distinct des données de dépôt ci-dessous

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

28Détenteurs suivis

-1Δ détenteurs

307.45MActions détenues

$239.60BValeur déclarée

+2Nouvelles positions

−3Sorties

Falling Score de conviction 39/100 Comment ces données sont calculées → Expliquer ceci au bureau de recherche →

Données momentum (gérants comparables) : étendue des détenteurs -3.4% · flux d'actions -1.6% · nouvelles positions nettes -3.6% — formule
Distribution large — baisse des parts et moins de détenteurs

Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q2 2025

Évolution de la détention dans le temps

Trimestre	Détenteurs	Δ	Actions	Valeur déclarée	Nouveau	Sorties
Q2 2026	193	+4	671.92M	$804.91B	+6	−1
Q1 2026	191	-3	666.59M	$613.20B	+1	−5
Q4 2025	193	+2	707.04M	$758.81B	+3	—
Q3 2025	27	-3	329.88M	$251.63B	+2	−6
Q2 2025	28	-1	307.45M	$239.60B	+2	−3
Q1 2025	26	0	140.32M	$115.83B	+1	−1
Q4 2024	26	+1	145.00M	$111.91B	+3	−2
Q3 2024	24	+2	109.89M	$97.29B	+2	—
Q2 2024	22	—	112.43M	$101.75B	—	—

Nombre de détenteurs

Qui le détient · Q2 2025

#	Gérant	Actions	Δ actions	Valeur	Leur poids		Détenu
1	The Vanguard Group ✦ (passif)	80.41M	—	$62.68B	1.0%	n/c	1	SEC ↗
2	The Vanguard Group ✦ (passif)	80.41M	—	$62.68B	1.0%	n/c	1	SEC ↗
3	The Vanguard Group ✦ (passif)	80.41M	—	$62.68B	1.0%	n/c	1	SEC ↗
4	The Vanguard Group ✦ (passif)	80.41M	—	$62.68B	1.0%	n/c	1	SEC ↗
5	The Vanguard Group ✦ (passif)	80.41M	—	$62.68B	1.0%	n/c	1	SEC ↗
6	The Vanguard Group ✦ (passif)	80.41M	—	$62.68B	1.0%	n/c	1	SEC ↗
7	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
8	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
9	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
10	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
11	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
12	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
13	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
14	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
15	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
16	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
17	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
18	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
19	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
20	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
21	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
22	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
23	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
24	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
25	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
26	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
27	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
28	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
29	BlackRock ✦ (passif)	65.96M	—	$51.42B	1.0%	n/c	1	SEC ↗
30	State Street Global Advisors ✦ (passif)	34.51M	+0.2%	$26.90B	1.0%	▲ Add	3	SEC ↗
31	Fidelity (FMR) ✦	25.63M	—	$19.98B	1.1%	n/c	1	SEC ↗
32	Fidelity (FMR) ✦	25.63M	—	$19.98B	1.1%	n/c	1	SEC ↗
33	Fidelity (FMR) ✦	25.63M	—	$19.98B	1.1%	n/c	1	SEC ↗
34	Fidelity (FMR) ✦	25.63M	—	$19.98B	1.1%	n/c	1	SEC ↗
35	Fidelity (FMR) ✦	25.63M	—	$19.98B	1.1%	n/c	1	SEC ↗
36	Fidelity (FMR) ✦	25.63M	—	$19.98B	1.1%	n/c	1	SEC ↗
37	Geode Capital Management ✦ (passif)	18.13M	-2.1%	$14.07B	1.0%	▼ Trim	5	SEC ↗
38	Geode Capital Management ✦ (passif)	18.13M	-2.1%	$14.07B	1.0%	▼ Trim	5	SEC ↗
39	Capital World Investors ✦	17.63M	-4.1%	$13.75B	2.0%	▼ Trim	5	SEC ↗
40	T. Rowe Price ✦	16.85M	-12.0%	$13.13B	1.5%	▼ Trim	5	SEC ↗
41	T. Rowe Price ✦	16.85M	-12.0%	$13.13B	1.5%	▼ Trim	5	SEC ↗
42	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
43	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
44	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
45	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
46	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
47	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
48	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
49	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
50	Wellington Management ✦	13.99M	+10.1%	$10.91B	2.0%	▲ Add	5	SEC ↗
51	PRIMECAP Management ✦	12.15M	-17.8%	$9.48B	7.5%	▼ Trim	5	SEC ↗
52	Norges Bank ✦ (passif)	11.32M	+3.0%	$8.83B	1.1%	▲ Add	5	SEC ↗
53	Fisher Asset Management ✦	4.30M	-20.9%	$3.35B	1.3%	▼ Trim	5	SEC ↗
54	Tiger Global Management ✦	1.51M	+13.2%	$1.18B	3.5%	▲ Add	5	SEC ↗
55	Marshall Wace ✦	931.73K	+122.1%	$726.31M	0.9%	▲ Add	5	SEC ↗
56	Marshall Wace ✦	931.73K	+122.1%	$726.31M	0.9%	▲ Add	5	SEC ↗
57	Marshall Wace ✦	931.73K	+122.1%	$726.31M	0.9%	▲ Add	5	SEC ↗
58	Citadel Advisors ✦	853.25K	+78.6%	$665.14M	0.6%	▲ Add	5	SEC ↗
59	Citadel Advisors ✦	853.25K	+78.6%	$665.14M	0.6%	▲ Add	5	SEC ↗
60	Adage Capital Partners ✦	841.81K	+13.5%	$656.22M	1.1%	▲ Add	5	SEC ↗
61	Millennium Management ✦	570.89K	-16.2%	$445.03M	0.4%	▼ Trim	5	SEC ↗
62	D. E. Shaw & Co. ✦	528.13K	-7.9%	$411.69M	0.4%	▼ Trim	5	SEC ↗
63	D. E. Shaw & Co. ✦	528.13K	-7.9%	$411.69M	0.4%	▼ Trim	5	SEC ↗
64	Viking Global Investors ✦	416.92K	Nouveau	$325.00M	0.9%	New	1	SEC ↗
65	AQR Capital Management ✦	346.98K	-38.9%	$269.65M	0.2%	▼ Trim	5	SEC ↗
66	AQR Capital Management ✦	346.98K	-38.9%	$269.65M	0.2%	▼ Trim	5	SEC ↗
67	AQR Capital Management ✦	346.98K	-38.9%	$269.65M	0.2%	▼ Trim	5	SEC ↗
68	AQR Capital Management ✦	346.98K	-38.9%	$269.65M	0.2%	▼ Trim	5	SEC ↗
69	AQR Capital Management ✦	346.98K	-38.9%	$269.65M	0.2%	▼ Trim	5	SEC ↗
70	AQR Capital Management ✦	346.98K	-38.9%	$269.65M	0.2%	▼ Trim	5	SEC ↗
71	Point72 Asset Management ✦	188.51K	+244.2%	$146.95M	0.4%	▲ Add	2	SEC ↗
72	Coatue Management ✦	117.42K	-36.1%	$91.53M	0.3%	▼ Trim	5	SEC ↗
73	Coatue Management ✦	117.42K	-36.1%	$91.53M	0.3%	▼ Trim	5	SEC ↗
74	Duquesne Family Office ✦	100.67K	+6.2%	$78.48M	2.0%	▲ Add	3	SEC ↗
75	Two Sigma Investments ✦	73.75K	+368.8%	$57.49M	0.1%	▲ Add	5	SEC ↗
76	Dodge & Cox ✦	44.96K	-0.3%	$35.05M	0.0%	▼ Trim	5	SEC ↗
77	GAMCO Investors ✦	27.40K	-8.9%	$21.36M	0.2%	▼ Trim	5	SEC ↗
78	Gotham Asset Management ✦	7.19K	-4.8%	$5.60M	0.0%	▼ Trim	5	SEC ↗
79	Harris Associates (Oakmark) ✦	414	Nouveau	$322,725	0.0%	New	1	SEC ↗
80	Renaissance Technologies ✦	261	-99.7%	$204,662	0.0%	▼ Trim	4	SEC ↗

« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.

Nouveaux acheteurs

Viking Global Investors	$325.00M	0.9%
Harris Associates (Oakmark)	$322,725	0.0%

Sorti(e)

Lone Pine Capital	$455.76M	était 4.0%
Arrowstreet Capital	$34.20M	était 0.0%
Bridgewater Associates	$2.27M	était 0.0%

Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 4,323 détenteurs, 762.84M actions, $674.93B déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.

Fréquemment codétenus

Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.

AVGO27détenteurs communs META27détenteurs communs MSFT27détenteurs communs AMZN26détenteurs communs GOOGL26détenteurs communs

Transactions d'initiés

Achats sur le marché libre (P)

Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.

Ventes sur le marché libre (S)

Aug 17 Jonsson Patrik

Officer · 6.50K act. · $7.64M

Aug 10 Zakrowski Donald A

Officer · 2.00K act. · $2.37M

Aug 07 Hakim Anat

Officer · 5.00K act. · $5.95M

Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie

Propriété bénéficiaire

Jul 23 SC 13G/A — LILLY ENDOWMENT INC

Consulter le dépôt SEC original ↗

Dans l'actualité

Aug 24 FDA Clears Roche And Eli Lilly's Alzheimer's Blood Test ↗

The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify…

Forbes

Aug 24 FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly ↗

The Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms, which was developed…

WSJ

Aug 24 Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance ↗

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help identify signs of…

Reuters

Aug 24 Eli Lilly Launches Foundayo Weight-Loss Pill in U.K. ↗

The once-daily pill was approved for patients with a body mass index of at least 30, or between 27 and 30 in the event…

WSJ

Aug 23 Eli Lilly launches oral weight-loss pill Foundayo in UK ↗

Eli Lilly said on Monday it has launched its oral pill, Foundayo, in the UK for weight ‌management and type 2…